Table 3.
Transgenic mouse models of exocytosis protein overexpression
| Genotype | Alteration | Metabolic Phenotype | Ref. No(s). |
|---|---|---|---|
| STX1A | Increased STX1A in pancreatic β cells | Fasting hyperglycemia, reduced insulin secretion, insulin intolerance in male mice | 58 |
| STX4 | Increased STX4 in skeletal muscle, fat, and pancreas | Enhanced insulin sensitivity, GLUT4 translocation and skeletal muscle glucose uptake; enhanced insulin secretion from islets; increased healthspan, lifespan; protected from age- and HFD-induced metabolic dysfunction | 76, 78, 106, 108 |
| VAMP2 | Increased VAMP2 in neurons | ND | 64 |
| Munc18-1 | Increased Munc18-1 in neurons | ND | 114 |
| Munc18c | Increased Munc18c in fat, skeletal muscle and pancreas | Insulin resistant, glucose intolerant with impaired skeletal muscle glucose uptake; impaired insulin secretion from islets | 107 |
| DOC2B | Increased DOC2B in skeletal muscle, fat, and pancreas | Enhanced insulin sensitivity, GLUT4 translocation and skeletal muscle glucose uptake; enhanced insulin secretion from islets |
90 |
STX1A and -4, syntaxin 1A and 4, respectively; GLUT4, glucose transporter 4; ND, not determined; HFD, high-fat diet.